Shire alleges trial info “unlawfully disparages” its product.
Silence claims late-stage drugs infringe patents.
MSD may have abused dominant market position, says CMA.
US authorities suspicious over marketing, rebates and payment support programmes.
Order comes after man commits suicide taking generic version of GSK’s Paxil.
Decision paves way for cheaper competitor in autumn 2018.
Biosimilars firm facing court battle.
Firms colluded to hike prices, says competition watchdog.
US authorities probing several other drugmakers amid pricing row.
